Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute Leukemia Relapse after Hematopoietic Stem Cell Transplantation: The Good, the Bad, and the Ugly of Isolated Extramedullary Relapse in a Latin American Population.
Arias-Espinosa L, Acosta-Medina AA, Vargas-España A, Fuentes-Martin V, Colunga-Pedraza PR, Hawing-Zarate JA, Leon AG, Soto-Mota A, Pacheco-Gutierrez G, Vargas-Serafín C, Barrera-Lumbreras G, Bourlon C. Arias-Espinosa L, et al. Transplant Cell Ther. 2023 Aug;29(8):510.e1-510.e9. doi: 10.1016/j.jtct.2023.05.006. Epub 2023 May 10. Transplant Cell Ther. 2023. PMID: 37169289 Free article.
Reduced-dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study.
Gutiérrez-Aguirre CH, Alvarado-Navarro DM, Palomares-Leal A, Mejía-Jaramillo G, Salazar-Riojas R, León AG, Colunga-Pedraza PR, Sotomayor-Duque G, Jaime-Pérez JC, Cantú-Rodríguez OG, Del Carmen Tarín-Arzaga L, Flores-Jiménez JA, Gómez-Almaguer D. Gutiérrez-Aguirre CH, et al. Transfusion. 2019 Dec;59(12):3721-3726. doi: 10.1111/trf.15547. Epub 2019 Oct 16. Transfusion. 2019. PMID: 31618456 Clinical Trial.
Outpatient Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide Is Safe and Feasible.
Colunga-Pedraza PR, Gómez-De León A, Rodríguez-Roque CS, Morcos-Sandino M, Colunga-Pedraza JE, Cantú-Rodriguez OG, Gutiérrez-Aguirre CH, Gómez-Almaguer D. Colunga-Pedraza PR, et al. Transplant Cell Ther. 2021 Mar;27(3):259.e1-259.e6. doi: 10.1016/j.jtct.2020.12.006. Epub 2020 Dec 16. Transplant Cell Ther. 2021. PMID: 33781529 Free article.
Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia.
Reyes Mondragón AL, Cantú-Rodríguez OG, Garza-Acosta AC, Gutiérrez-Aguirre CH, Colunga Pedraza PR, Del Carmen Tarín-Arzaga L, Jaime-Pérez JC, Hawing Zárate JA, González-Cantú GA, Villalobos-Gutiérrez LE, Jiménez-Castillo RA, Vera-Pineda R, Gómez-Almaguer D. Reyes Mondragón AL, et al. Blood Cells Mol Dis. 2021 Sep;90:102586. doi: 10.1016/j.bcmd.2021.102586. Epub 2021 Jun 2. Blood Cells Mol Dis. 2021. PMID: 34126299
Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery.
León AG, Gil-Flores L, Colunga-Pedraza P, Bourlon C, Vargas-Serafín C, Del Campo-Martínez MLÁ, Olaya-Vargas A, Pérez-García M, González-Leal XJ, Herrera Rojas MA, Lozano-Rodríguez S, Solano-Genesta M, Rodríguez-Zúñiga AC, Sánchez-Arteaga A, Ruiz-Argüelles GJ, Gómez-Almaguer D; Transplantation and Cellular Therapy Working Group in Mexico (TCTMX). León AG, et al. Hematology. 2022 Dec;27(1):1294-1300. doi: 10.1080/16078454.2022.2156737. Hematology. 2022. PMID: 36516305 Free article.
Global representation among journal editors in haematology: are we diverse, equitable, and inclusive?
Noyola-Pérez A, Gil-Flores L, Martínez-Espinosa HA, Ramos-Barrera E, Rodríguez-González V, Sung L, Guzman M, Hamad N, Colunga-Pedraza PR, Tarín-Arzaga L, Cantú-Rodríguez OG, Gutiérrez-Aguirre H, Jaime-Pérez JC, Gómez-Almaguer D, León AG. Noyola-Pérez A, et al. Lancet Haematol. 2023 Apr;10(4):e246-e247. doi: 10.1016/S2352-3026(23)00069-8. Lancet Haematol. 2023. PMID: 36990621 No abstract available.
Obesity is associated with higher overall survival in patients undergoing an outpatient reduced-intensity conditioning hematopoietic stem cell transplant.
Jaime-Pérez JC, Colunga-Pedraza PR, Gutiérrez-Gurrola B, Brito-Ramírez AS, Gutiérrez-Aguirre H, Cantú-Rodríguez OG, Herrera-Garza JL, Gómez-Almaguer D. Jaime-Pérez JC, et al. Blood Cells Mol Dis. 2013 Jun;51(1):61-5. doi: 10.1016/j.bcmd.2013.01.010. Epub 2013 Feb 16. Blood Cells Mol Dis. 2013. PMID: 23422842
Outpatient low toxic regimen with bortezomib in relapsed/refractory acute lymphoblastic leukemia in pediatrics and AYA patients: Single-center Mexican experience.
Colunga-Pedraza JE, González-Llano O, González-Martinez CE, Gómez-Almaguer D, Yáñez-Reyes JM, Jiménez-Antolinez V, Colunga-Pedraza PR. Colunga-Pedraza JE, et al. Pediatr Blood Cancer. 2020 May;67(5):e28241. doi: 10.1002/pbc.28241. Epub 2020 Mar 11. Pediatr Blood Cancer. 2020. PMID: 32159276
Outpatient transplantation in the COVID-19 era: a single-center Latin American experience.
Colunga-Pedraza PR, Colunga-Pedraza JE, Meléndez-Flores JD, González-Treviño M, Ramos-Dávila EM, Gómez-De León A, Peña-Lozano SP, González-Llano Ó, Cantú-Rodríguez OG, Bustillos-Muñoz M, Gutiérrez-Aguirre CH, Gómez-Almaguer D, Jaime-Pérez JC. Colunga-Pedraza PR, et al. Bone Marrow Transplant. 2021 Sep;56(9):2287-2290. doi: 10.1038/s41409-021-01360-4. Epub 2021 May 27. Bone Marrow Transplant. 2021. PMID: 34045692 Free PMC article. No abstract available.
Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America.
Gómez-De León A, Demichelis-Gómez R, Pinedo-Rodríguez A, Enriquez-Vera D, Flores-Jiménez JA, Ceballos-López AA, Rodríguez-Mejorada M, Herrera Riojas MA, Ovilla-Martínez R, Báez-Islas P, Cota-Rangel X, Neme-Yunes Y, Inclán-Alarcón S, López-Flores NJ, Colunga-Pedraza PR, Rodríguez-Zúñiga AC, Gómez-Almaguer D. Gómez-De León A, et al. Hematology. 2022 Dec;27(1):249-257. doi: 10.1080/16078454.2021.2024940. Hematology. 2022. PMID: 35192778 Free article.
65 results